Bendazac

CAT: 0804-HY-17480-01Size: 100 mgDry Ice: NoHazardous: No
CAT#:0804-HY-17480-01Size:100 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process. Bendazac exerts funciton in anti-radical effect and inhibits oxidative brust[1][2][3].
CAS Number
[20187-55-7]
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bendazac.html
Purity
99.92
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Molecular Formula
C16H14N2O3
Molecular Weight
282.29
Precautions
H302, H312, H332
References & Citations
[1]Balfour JA, et al. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs. 1990;39 (4) :575-596.|[2]Guglielmotti A, et al. Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent. Pharmacol Res. 1995;32 (6) :369-373.|[3]Musci G, et al. Mechanism of the scavenger-like activity of bendazac. Drugs Exp Clin Res. 1987;13 (5) :289-292.|[4]Guglielmotti A, et al. Anti-radical effects and oxidative burst inhibition of bendazac, an anticataract nonsteroidal antiinflammatory agent[J]. Pharmacological Research, 1995, 31: 360.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
Patent. US20240216332A1.|Patent. US20240216332A1.

Related Products

Popular Products